Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-04

FDA Approved: OXALIPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic Oxaliplatin product from Fresenius Kabi USA, LLC. This approval permits marketing of the generic oxaliplat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)